Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma

被引:7
作者
Alghamdi, Rana A. [1 ]
Al-Zahrani, Maryam H. [2 ]
机构
[1] King Abdulaziz Univ, Sci & Arts Coll, Dept Chem, Rabigh, Saudi Arabia
[2] King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah, Saudi Arabia
关键词
Lung malignancies; Bioinformatics methods; Hub genes; Tumor immunity; Diagnostic efficiency; Lung Squamous Cell Carcinoma; EXPRESSION; PATHWAYS; MARKERS;
D O I
10.1016/j.sjbs.2023.103596
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Lung Squamous Cell Carcinoma (LUSC) is a major subtype of lung malignancies and is asso-ciated with the cause of cancer-mediated mortality worldwide. However, identification of transcriptomic signatures associated with survival-prognosis and immunity of tumor remains lackingMethod: The GSE2088, GSE6044, GSE19188, GSE21933, GSE33479, GSE33532, and GSE74706 were inte-grated for identifying differentially expressed genes (DEGs) with combined effect sizes. Also, the TCGA LUSC cohort was used for further analysis. A series of bioinformatics methods were utilized for conduct-ing the whole study.Results: The 831 genes (such as DSG3, PKP1, DSC3, TPX2, and UBE2C) were found upregulated and the 731 genes (such as ABCA8, SELENBP1, FAM107A, and CACNA2D2) were downregulated in the LUSC. The func-tional enrichment analysis identifies the upregulated KEGG pathways, including cell cycle, DNA replica-tion, base excision repair, proteasome, mismatch repair, and cellular senescence. Also, the key hub genes (such as EGFR, HRAS, JUN, CDH1, BRCA1, CASP3, RHOA, HDAC1, HIF1A, and CCNA2) were identified along with the eight gene modules that were significantly related to the protein-protein interaction (PPI). The clinical analyses identified that the overexpression group of CDH3, PLAU, PKP3, STIL, CALU, LOXL2, POSTN, DPP3, GALNT2, LOX, and ITPA are substantially associated with a poor survival prognosis and the downregulated group of IL18R1 showed a similar trend. Moreover, our investigation demonstrated that the survival-associated genes were correlated with the stromal and immune scores in LUSC, indicat-ing that the survival-associated genes regulate tumor immunity. The survival-associated genes were genetically altered in 27% of LUSC patients and showed excellent diagnostic efficiency. Finally, the con-sistent expression level of CDH3, PLAU, PKP3, STIL, CALU, LOXL2, POSTN, DPP3, GALNT2, and ITPA were found in the TCGA LUSC cohort Conclusions: The identification of key transcriptomic signatures can be elucidated by the crucial mecha-nism of LUSC carcinogenesis.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:15
相关论文
共 67 条
  • [11] Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer
    Chen, Binglin
    Xie, Xiaowei
    Lan, Feifeng
    Liu, Wenqi
    [J]. BIOENGINEERED, 2021, 12 (01) : 4924 - 4935
  • [12] Tophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma
    Chen, Zhao
    Zhou, Yuhan
    Luo, Raojun
    Liu, Kai
    Chen, Zhoumiao
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 2043 - +
  • [13] cytoHubba: identifying hub objects and sub-networks from complex interactome
    Chin, Chia-Hao
    Chen, Shu-Hwa
    Wu, Hsin-Hung
    Ho, Chin-Wen
    Ko, Ming-Tat
    Lin, Chung-Yen
    [J]. BMC SYSTEMS BIOLOGY, 2014, 8
  • [14] Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
    Choi, M.
    Kadara, H.
    Zhang, J.
    Parra, E. R.
    Rodriguez-Canales, J.
    Gaffney, S. G.
    Zhao, Z.
    Behrens, C.
    Fujimoto, J.
    Chow, C.
    Kim, K.
    Kalhor, N.
    Moran, C.
    Rimm, D.
    Swisher, S.
    Gibbons, D. L.
    Heymach, J.
    Kaftan, E.
    Townsend, J. P.
    Lynch, T. J.
    Schlessinger, J.
    Lee, J.
    Lifton, R. P.
    Herbst, R. S.
    Wistuba, I. I.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (01) : 83 - 89
  • [15] ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway
    Cui, Yifeng
    Liang, Shuhang
    Zhang, Shugeng
    Zhang, Congyi
    Zhao, Yunzheng
    Wu, Dehai
    Wang, Jiabei
    Song, Ruipeng
    Wang, Jizhou
    Yin, Dalong
    Liu, Yao
    Pan, Shangha
    Liu, Xirui
    Wang, Yan
    Han, Jihua
    Meng, Fanzheng
    Zhang, Bo
    Guo, Hongrui
    Lu, Zhaoyang
    Liu, Lianxin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [16] Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
    Davoli, Teresa
    Uno, Hajime
    Wooten, Eric C.
    Elledge, Stephen J.
    [J]. SCIENCE, 2017, 355 (6322)
  • [17] Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Dong, Yanting
    Li, Shicheng
    Sun, Xiao
    Wang, Yuanyong
    Lu, Tong
    Wo, Yang
    Leng, Xiaoliang
    Kong, Dezhi
    Jiao, Wenjie
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 11111 - 11124
  • [18] Role of cell cycle regulators in lung carcinogenesis
    Eymin, Beatrice
    Gazzeri, Sylvie
    [J]. CELL ADHESION & MIGRATION, 2010, 4 (01) : 114 - 123
  • [19] ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis
    Fujiwara, Takeshi
    Hiramatsu, Miyako
    Isagawa, Takayuki
    Ninomiya, Hironori
    Inamura, Kentaro
    Ishikawa, Shumpei
    Ushijima, Masaru
    Matsuura, Masaaki
    Jones, Michael H.
    Shimane, Miyuki
    Nomura, Hitoshi
    Ishikawa, Yuichi
    Aburatani, Hiroyuki
    [J]. LUNG CANCER, 2012, 75 (01) : 119 - 125
  • [20] EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
    Gong, Hao
    Li, Yongwen
    Yuan, Yin
    Li, Weiting
    Zhang, Hongbing
    Zhang, Zihe
    Shi, Ruifeng
    Liu, Minghui
    Liu, Chao
    Chen, Chen
    Liu, Hongyu
    Chen, Jun
    [J]. BMC CANCER, 2020, 20 (01)